Abvc Biopharma (ABVC) Construction in Progress (2023 - 2025)

Abvc Biopharma's (ABVC) quarterly Construction in Progress came in at $691900.0 in Q3 2025, down 90.65% on a QoQ basis from $7.4 million in Q2 2025.

Abvc Biopharma (ABVC) Construction in Progress (2023 - 2025) Analysis & Trends

Abvc Biopharma (ABVC) has 3 years of Construction in Progress data on file, last reported at $691900.0 in Q3 2025.

Quarterly Construction in Progress changed N/A year-over-year to $691900.0 in Q3 2025, while the trailing twelve-month figure through Sep 2025 was $691900.0 (changed N/A YoY) and the FY2024 annual result came in at $691900.0, up 21.54% from the prior year.
Construction in Progress declined to $691900.0 in Q3 2025, from $7.4 million in the prior quarter.
In the past five years, Construction in Progress ranged from a high of $7.4 million in Q1 2025 to a low of $529121.0 in Q2 2024.
A 3-year average of $2.5 million and a median of $691900.0 in 2024 frame the typical range for Construction in Progress.
Annual changes were most pronounced in 2024 — Construction in Progress climbed 21.54% — and 2025, when it surged 1298.55%.
Tracing ABVC's Construction in Progress over 3 years: stood at $569278.0 in 2023, then grew by 21.54% to $691900.0 in 2024, then changed by 0.0% to $691900.0 in 2025.
The last three Construction in Progress figures came in at $691900.0 (Q3 2025), $7.4 million (Q2 2025), and $7.4 million (Q1 2025), per Business Quant data.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Construction in Progress (Qtr)
1	Vertex Pharmaceuticals	139.47 Bn	131.61 Bn	2.84 Bn	-
2	Regeneron Pharmaceuticals	86.36 Bn	78.37 Bn	3.93 Bn	-
3	Argenx Se	65.16 Bn	59.98 Bn	1.37 Bn	-
4	Moderna	58.99 Bn	53.85 Bn	52.00 Mn	-
5	BeOne Medicines	42.08 Bn	36.98 Bn	1.53 Bn	152.67 Mn
6	Alnylam Pharmaceuticals	31.74 Bn	28.43 Bn	992.69 Mn	-
7	BioNTech SE	28.01 Bn	9.61 Bn	668.28 Mn	-
8	Insmed	27.50 Bn	26.34 Bn	358.27 Mn	-
9	Royalty Pharma	27.28 Bn	26.45 Bn	-	-
10	Abvc Biopharma	24.11 Mn	24.11 Mn	-	-

Download Data